Time-dependent Interactions of Blood Platelets and Cancer Cells, Accompanied by Extramedullary Hematopoiesis, Lead to Increased Platelet Activation and Reactivity in a Mouse Orthotopic Model of Breast Cancer - Implications for Pulmonary and Liver...

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2020 Mar 20

PMID 32191918

Citations 12

Authors

Hassan Kassassir

Kamil Karolczak

Karolina M Siewiera

Dagmara W Wojkowska

Marcin Braun

Cezary W Watala

Affiliations

Soon will be listed here.

Abstract

Aging has become a significant risk factor for several diseases, including breast cancer.Platelet activation and platelet-cancer cell aggregate fractions were found to increase with tumor progression in a mouse model of breast cancer. At advanced stages of tumor development, platelets from mice with breast cancer were hyperreactive to low agonist concentrations and hyporeactive to high ones. Platelet activation and reactivity were strongly associated with breast cancer metastasis in the lungs and extramedullary hematopoiesis in the liver. A greater fraction of platelet aggregates was observed in 4T1-injected mice at the advanced stages of breast cancer. , platelet activation was elevated after incubation with 4T1 cells, and thrombin-stimulated platelets formed aggregates with 4T1 cells. Neither GPIbα, nor GPIIb/IIIa blocking antibodies, were able to affect platelet-cancer cell aggregation .The primed circulating platelets became more sensitive to subthreshold stimuli at advanced stages of tumor development, and the formation of platelet-cancer cell aggregates increased with cancer progression. Our findings demonstrate that the age-associated progression of breast cancer cells is connected with increased platelet functioning, and that it can be manifested by the increased number of metastases and extramedullary hematopoiesis in a time-dependent-manner.

Citing Articles

Distant metastasis of oral squamous cell carcinoma: immune escape mechanism and new perspectives on treatment.

He L, Wan M, Yang X, Meng H Discov Oncol. 2025; 16(1):257.

PMID: 40024975 PMC: 11872995. DOI: 10.1007/s12672-025-01997-3.

Preclinical safety and effectiveness of a long-acting somatostatin analogue [Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors.

Njotu F, Pougoue Ketchemen J, Babeker H, Henning N, Tikum A, Nwangele E Eur J Nucl Med Mol Imaging. 2024; 52(4):1305-1320.

PMID: 39627348 DOI: 10.1007/s00259-024-07011-2.

TEP RNA: a new frontier for early diagnosis of NSCLC.

Wang Y, Dong A, Jin M, Li S, Duan Y J Cancer Res Clin Oncol. 2024; 150(2):97.

PMID: 38372784 PMC: 10876732. DOI: 10.1007/s00432-024-05620-w.

Chemotherapy following immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: clinical effectiveness and influence of inflammatory and nutritional factors.

Sakai A, Ebisumoto K, Iijima H, Yamauchi M, Teramura T, Yamazaki A Discov Oncol. 2023; 14(1):158.

PMID: 37642856 PMC: 10465419. DOI: 10.1007/s12672-023-00774-4.

The Progress of Platelets in Breast Cancer.

Wang L, Zhang K, Feng J, Wang D, Liu J Cancer Manag Res. 2023; 15:811-821.

PMID: 37589033 PMC: 10426457. DOI: 10.2147/CMAR.S418574.

References

Rossaint J, Kuhne K, Skupski J, Van Aken H, Looney M, Hidalgo A . Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat Commun. 2016; 7:13464. PMC: 5116072. DOI: 10.1038/ncomms13464. View

Bottsford-Miller J, Choi H, Dalton H, Stone R, Cho M, Haemmerle M . Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res. 2014; 21(3):602-10. PMC: 4315757. DOI: 10.1158/1078-0432.CCR-14-0870. View

Cooke N, Spillane C, Sheils O, OLeary J, Kenny D . Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion. BMC Cancer. 2015; 15:627. PMC: 4565001. DOI: 10.1186/s12885-015-1634-x. View

Quinn M, Byzova T, Qin J, Topol E, Plow E . Integrin alphaIIbbeta3 and its antagonism. Arterioscler Thromb Vasc Biol. 2003; 23(6):945-52. DOI: 10.1161/01.ATV.0000066686.46338.F1. View

Laresche C, Pelletier F, Garnache-Ottou F, Lihoreau T, Biichle S, Mourey G . Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. J Invest Dermatol. 2013; 134(1):176-182. DOI: 10.1038/jid.2013.288. View

Rozalski M, Kassassir H, Siewiera K, Klepacka A, Sychowski R, Watala C . Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesis. Thromb Res. 2014; 133(6):1097-104. DOI: 10.1016/j.thromres.2014.03.041. View

Sarratt K, Chen H, Zutter M, Santoro S, Hammer D, Kahn M . GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood. 2005; 106(4):1268-77. PMC: 1895202. DOI: 10.1182/blood-2004-11-4434. View

Chou Y, Lee M, Wu M, Shih H, Yang T, Yu C . Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan. Breast Cancer Res Treat. 2006; 101(2):199-205. DOI: 10.1007/s10549-006-9278-9. View

Olas B, Wachowicz B, Mielicki W . Cancer procoagulant and blood platelet activation. Cancer Lett. 2001; 169(2):165-71. DOI: 10.1016/s0304-3835(01)00545-6. View

10.

Chen Z, Mondal N, Ding J, Koenig S, Slaughter M, Wu Z . Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor. Artif Organs. 2015; 40(7):659-68. PMC: 4871771. DOI: 10.1111/aor.12606. View

11.

Mattheij N, Gilio K, van Kruchten R, Jobe S, Wieschhaus A, Chishti A . Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets. J Biol Chem. 2013; 288(19):13325-36. PMC: 3650371. DOI: 10.1074/jbc.M112.428359. View

12.

Tsamandas A, Jain A, Raikow R, Demetris A, Nalesnik M, Randhawa P . Extramedullary hematopoiesis in the allograft liver. Mod Pathol. 1995; 8(6):671-4. View

13.

Liu Y, Jiang P, capkova K, Xue D, Ye L, Sinha S . Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res. 2011; 71(20):6492-502. DOI: 10.1158/0008-5472.CAN-11-1145. View

14.

Lonsdorf A, Kramer B, Fahrleitner M, Schonberger T, Gnerlich S, Ring S . Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. J Biol Chem. 2011; 287(3):2168-78. PMC: 3265895. DOI: 10.1074/jbc.M111.269811. View

15.

Macki M, Bydon M, Papademetriou K, Gokaslan Z, Bydon A . Presacral extramedullary hematopoiesis: an alternative hypothesis. J Clin Neurosci. 2013; 20(12):1664-8. DOI: 10.1016/j.jocn.2013.06.003. View

16.

Buczek E, Denslow A, Mateuszuk L, Proniewski B, Wojcik T, Sitek B . Alterations in NO- and PGI- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation. BMC Cancer. 2018; 18(1):582. PMC: 5964697. DOI: 10.1186/s12885-018-4445-z. View

17.

Gebremeskel S, LeVatte T, Liwski R, Johnston B, Bezuhly M . The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer. Int J Cancer. 2014; 136(1):234-40. DOI: 10.1002/ijc.28947. View

18.

Thomas G, Leonard R . How age affects the biology of breast cancer. Clin Oncol (R Coll Radiol). 2008; 21(2):81-5. DOI: 10.1016/j.clon.2008.11.006. View

19.

Bouillon K, Haddy N, Delaloge S, Garbay J, Garsi J, Brindel P . Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011; 57(4):445-52. DOI: 10.1016/j.jacc.2010.08.638. View

20.

De Meyer S, Schwarz T, Deckmyn H, Denis C, Nieswandt B, Stoll G . Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report. Arterioscler Thromb Vasc Biol. 2010; 30(10):1949-51. DOI: 10.1161/ATVBAHA.110.208918. View